Christiane Honisch
Pathoquest announced today that it has appointed Christiane Honisch as an independent member of the firm's board of directors. With over 15 years of experience developing markers, assays, software, and technology for infectious disease detection, Honisch is currently head of global business intelligence and development at Eppendorf. Prior to Eppendorf, Honisch served as director of microbiology markets at Illumina. Before working at Illumina, Honisch served as director of infectious disease research at Roche Molecular Diagnostics.
John Kraeutler, David Phillips, Felicia Williams
John (Jack) Kraeutler has retired from his position as Meridian Bioscience's executive chairman of the board, effective Sept. 30, 2018. Kraeutler retired as CEO of the firm last year after 25 years in that position. Meridian has appointed David Phillips as the new chairman of the board and has also elected Felicia Williams to the board of directors and to serve on the firm's audit committee, effective Sept. 20, 2018. Williams previously served in financial positions at Macy's and Coca-Cola.
Jonathan Seaton
GenomOncology has appointed Jonathan Seaton to its board of directors. Seaton is senior VP for corporate development at Illumina. Previously, he was VP of strategy and business development for life sciences at Becton Dickinson and has held multiple roles at Roche.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.